Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Mark Pruzanski. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Mark Pruzanski zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:ICPT / Intercept Pharmaceuticals Inc | Director | 0 |
| US:EQ / Equillium, Inc. | Director | 20 000 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Mark Pruzanski. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera EQ / Equillium, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w EQ / Equillium, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera EQ / Equillium, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w EQ / Equillium, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Mark Pruzanski ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
U - Other | -618 894 | 0 | -100,00 | 19,00 | -11 758 986 | ||
| 2022-05-25 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2021-12-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 817 | 618 894 | -0,61 | 17,21 | -65 691 | 10 651 166 | |
| 2021-12-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 622 711 | 1,00 | 17,21 | 105 635 | 10 716 856 | |
| 2021-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 817 | 616 573 | -0,62 | 16,86 | -64 355 | 10 395 421 | |
| 2021-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 620 390 | 1,00 | 16,86 | 103 487 | 10 459 775 | |
| 2021-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 816 | 614 252 | -0,62 | 14,85 | -56 668 | 9 121 642 | |
| 2021-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 136 | 618 068 | 1,00 | 14,85 | 91 120 | 9 178 310 | |
| 2021-09-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 817 | 611 932 | -0,62 | 14,91 | -56 911 | 9 123 906 | |
| 2021-09-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 615 749 | 1,01 | 14,91 | 91 518 | 9 180 818 | |
| 2021-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 817 | 609 611 | -0,62 | 17,28 | -65 958 | 10 534 078 | |
| 2021-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 613 428 | 1,01 | 17,28 | 106 065 | 10 600 036 | |
| 2021-07-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 816 | 607 290 | -0,62 | 19,97 | -76 206 | 12 127 581 | |
| 2021-07-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 136 | 611 106 | 1,01 | 19,97 | 122 536 | 12 203 787 | |
| 2021-06-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 817 | 604 970 | -0,63 | 16,63 | -63 477 | 10 060 651 | |
| 2021-06-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 608 787 | 1,02 | 16,63 | 102 075 | 10 124 128 | |
| 2021-05-28 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 20 770 | 20 770 | |||||
| 2021-05-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 817 | 502 649 | -0,75 | 19,78 | -75 500 | 9 942 397 | |
| 2021-05-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 506 466 | 1,23 | 19,78 | 121 410 | 10 017 897 | |
| 2021-04-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 658 | 500 328 | -0,73 | 23,08 | -84 427 | 11 547 570 | |
| 2021-04-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 136 | 503 986 | 1,23 | 23,08 | 141 619 | 11 631 997 | |
| 2021-03-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -2 741 | 497 850 | -0,55 | 21,66 | -59 370 | 10 783 431 | |
| 2021-03-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 500 591 | 1,24 | 21,66 | 132 949 | 10 842 801 | |
| 2021-02-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -2 741 | 494 453 | -0,55 | 35,24 | -96 593 | 17 424 524 | |
| 2021-02-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 497 194 | 1,25 | 35,24 | 216 303 | 17 521 117 | |
| 2021-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -632 | 491 056 | -0,13 | 24,70 | -15 610 | 12 129 083 | |
| 2021-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -25 065 | 491 688 | -4,85 | 24,70 | -619 106 | 12 144 694 | |
| 2021-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 41 236 | 516 753 | 8,67 | 24,70 | 1 018 529 | 12 763 799 | |
| 2020-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -772 | 475 517 | -0,16 | 42,08 | -32 486 | 20 009 755 | |
| 2020-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -772 | 476 289 | -0,16 | 46,52 | -35 913 | 22 156 964 | |
| 2020-05-21 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 24 000 | 24 000 | |||||
| 2020-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -568 | 477 061 | -0,12 | 58,40 | -33 171 | 27 860 362 | |
| 2020-01-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
A - Award | 17 700 | 17 700 | |||||
| 2020-01-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 800 | 477 629 | 2,31 | ||||
| 2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 166 | 466 829 | -0,25 | 123,92 | -144 491 | 57 849 450 | |
| 2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -100 | 30 084 | -0,33 | |||
| 2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 131 | 467 995 | -0,24 | 123,92 | -140 154 | 57 993 940 | |
| 2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -100 | 469 126 | -0,02 | 125,00 | -12 500 | 58 640 750 |
| 2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 100 | 469 226 | 0,02 | 21,50 | 2 150 | 10 088 359 |
| 2019-12-30 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -417 | 30 184 | -1,36 | |||
| 2019-12-30 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -417 | 469 126 | -0,09 | 125,00 | -52 125 | 58 640 750 |
| 2019-12-30 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 417 | 469 543 | 0,09 | 21,50 | 8 966 | 10 095 174 |
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -15 557 | 30 601 | -33,70 | |||
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -19 880 | 0 | -100,00 | |||
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -35 437 | 469 126 | -7,02 | 100,00 | -3 543 700 | 46 912 600 |
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 15 557 | 504 563 | 3,18 | 21,50 | 334 476 | 10 848 104 |
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 19 880 | 489 006 | 4,24 | 8,67 | 172 294 | 4 238 068 |
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -14 524 | 19 880 | -42,22 | |||
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -39 | 0 | -100,00 | |||
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -14 563 | 469 126 | -3,01 | 100,00 | -1 456 300 | 46 912 600 |
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 14 524 | 483 689 | 3,10 | 8,67 | 125 875 | 4 191 987 |
| 2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 39 | 469 165 | 0,01 | 8,67 | 338 | 4 066 112 |
| 2019-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 547 | 469 126 | -0,33 | 65,87 | -101 901 | 30 901 330 | |
| 2019-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 548 | 470 673 | -0,33 | 79,17 | -122 555 | 37 263 181 | |
| 2019-06-13 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
| 2019-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 547 | 472 221 | -0,33 | 111,50 | -172 490 | 52 652 642 | |
| 2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
A - Award | 13 700 | 13 700 | |||||
| 2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 500 | 573 768 | 1,50 | ||||
| 2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -1 537 | 565 268 | -0,27 | 100,79 | -154 914 | 56 973 362 | |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -27 606 | 39 | -99,86 | |||
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 988 | 566 805 | -0,35 | 103,29 | -205 333 | 58 543 021 |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -7 839 | 568 793 | -1,36 | 102,61 | -804 374 | 58 364 874 |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -7 949 | 576 632 | -1,36 | 101,48 | -806 687 | 58 518 230 |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -9 830 | 584 581 | -1,65 | 100,38 | -986 735 | 58 680 241 |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 27 606 | 594 411 | 4,87 | 8,67 | 239 253 | 5 151 582 |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | -22 394 | 27 645 | -44,75 | |||
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -3 521 | 566 805 | -0,62 | 101,13 | -356 088 | 57 322 520 |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -18 873 | 570 326 | -3,20 | 100,38 | -1 894 496 | 57 250 065 |
| 2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 22 394 | 589 199 | 3,95 | 8,67 | 194 082 | 5 106 411 |
| 2018-10-11 | 3 | EQ |
Equillium, Inc.
Common Stock |
47 598 | ||||||||
| 2018-10-11 | 3 | EQ |
Equillium, Inc.
Common Stock |
47 598 | ||||||||
| 2018-10-11 | 3 | EQ |
Equillium, Inc.
Common Stock |
47 598 | ||||||||
| 2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -2 049 | 566 805 | -0,36 | 126,46 | -259 117 | 71 678 160 | |
| 2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -2 051 | 566 805 | -0,36 | 83,91 | -172 099 | 47 560 608 | |
| 2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -2 050 | 566 805 | -0,36 | 61,52 | -126 116 | 34 869 844 | |
| 2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -3 609 | 566 805 | -0,63 | 58,42 | -210 838 | 33 112 748 | |
| 2018-04-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 812 | 576 564 | 1,37 | 64,00 | 499 968 | 36 900 096 | |
| 2018-02-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 45 500 | 45 500 | |||||
| 2017-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 532 | 568 752 | -0,27 | 58,87 | -90 189 | 33 482 430 | |
| 2017-07-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 434 | 570 284 | -0,25 | 121,78 | -174 633 | 69 449 186 | |
| 2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -40 000 | 50 039 | -44,43 | |||
| 2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 043 | 571 718 | -0,36 | 133,07 | -271 872 | 76 081 316 |
| 2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 485 | 573 761 | -0,95 | 132,54 | -726 996 | 76 047 717 |
| 2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 893 | 579 246 | -1,01 | 131,18 | -773 050 | 75 986 070 |
| 2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -18 763 | 585 139 | -3,11 | 130,46 | -2 447 845 | 76 337 995 |
| 2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -7 816 | 603 902 | -1,28 | 129,49 | -1 012 101 | 78 199 813 |
| 2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 40 000 | 611 718 | 7,00 | 8,67 | 346 668 | 5 301 576 |
| 2017-04-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 | 571 718 | 0,00 | 115,00 | -137 | 65 746 026 | |
| 2017-02-14 |
|
5 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
G - Gift | -3 000 | 572 905 | -0,52 | ||||
| 2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 40 000 | 40 000 | |||||
| 2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 23 200 | 575 905 | 4,20 | ||||
| 2017-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 802 | 552 705 | -0,50 | 103,92 | -291 181 | 57 436 606 | |
| 2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -2 405 | 1 354 | -63,98 | ||||
| 2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -1 082 | 0 | -100,00 | ||||
| 2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 405 | 555 507 | 0,43 | 31,90 | 76 720 | 17 720 673 | |
| 2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 082 | 553 102 | 0,20 | 21,50 | 23 263 | 11 891 693 | |
| 2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -705 | 552 020 | -0,13 | 163,20 | -115 056 | 90 089 498 | |
| 2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -8 411 | 0 | -100,00 | |||
| 2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -26 589 | 90 039 | -22,80 | |||
| 2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -35 000 | 552 725 | -5,96 | 165,00 | -5 775 000 | 91 199 625 |
| 2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 411 | 587 725 | 1,45 | 9,82 | 82 615 | 5 772 811 |
| 2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 26 589 | 579 314 | 4,81 | 8,67 | 230 439 | 5 020 741 |
| 2016-07-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -12 500 | 0 | -100,00 | ||||
| 2016-07-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
F - Taxes | -7 341 | 552 725 | -1,31 | 148,73 | -1 091 827 | 82 206 789 | |
| 2016-07-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 500 | 560 066 | 2,28 | 9,82 | 122 779 | 5 501 136 | |
| 2016-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -714 | 547 566 | -0,13 | 145,11 | -103 608 | 79 456 864 | |
| 2016-04-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -708 | 548 248 | -0,13 | 130,76 | -92 578 | 71 688 908 | |
| 2016-02-16 |
|
5 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
G - Gift | -3 900 | 548 956 | -0,71 | ||||
| 2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 30 500 | 30 500 | |||||
| 2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 23 300 | 552 856 | 4,40 | ||||
| 2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -125 | 529 556 | -0,02 | 145,90 | -18 238 | 77 264 180 | |
| 2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 001 | 529 681 | -0,38 | 145,90 | -291 953 | 77 282 418 | |
| 2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 0 | -100,00 | ||||
| 2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 531 682 | 0,92 | ||||
| 2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -167 | 526 814 | -0,03 | 159,04 | -26 560 | 83 784 130 | |
| 2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | -4 867 | 4 868 | -49,99 | ||||
| 2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 32 550 | 32 550 | |||||
| 2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 867 | 526 981 | 0,93 | ||||
| 2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 15 100 | 522 114 | 2,98 | ||||
| 2015-07-14 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -12 500 | 116 628 | -9,68 | |||
| 2015-07-14 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 500 | 507 014 | -2,41 | 250,00 | -3 125 000 | 126 753 500 |
| 2015-07-14 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 519 514 | 2,47 | 8,67 | 108 334 | 4 502 472 |
| 2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 | 507 014 | 0,00 | 239,00 | -478 | 121 176 397 | |
| 2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -7 | 507 016 | 0,00 | 238,16 | -1 667 | 120 750 981 | |
| 2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -149 | 507 023 | -0,03 | 236,13 | -35 183 | 119 723 341 | |
| 2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 9 735 | -33,34 | ||||
| 2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 507 172 | 0,97 | ||||
| 2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -4 651 | 47 240 | -8,96 | ||||
| 2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -1 910 | 34 404 | -5,26 | ||||
| 2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 651 | 502 304 | 0,93 | 21,50 | 99 996 | 10 799 536 | |
| 2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 910 | 497 653 | 0,39 | 8,67 | 16 553 | 4 313 009 | |
| 2015-05-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -5 000 | 129 128 | -3,73 | |||
| 2015-05-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 495 743 | -1,00 | 300,00 | -1 500 000 | 148 722 900 |
| 2015-05-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 500 743 | 1,01 | 8,67 | 43 334 | 4 339 789 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -12 500 | 134 128 | -8,52 | |||
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -312 | 495 743 | -0,06 | 259,33 | -80 912 | 128 563 114 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -400 | 496 055 | -0,08 | 258,50 | -103 400 | 128 230 218 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 496 455 | -0,04 | 256,42 | -51 283 | 127 298 509 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -661 | 496 655 | -0,13 | 255,49 | -168 881 | 126 892 025 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 539 | 497 316 | -0,31 | 254,63 | -391 881 | 126 633 264 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 338 | 498 855 | -0,86 | 253,52 | -1 099 791 | 126 472 114 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 350 | 503 193 | -0,66 | 252,53 | -845 979 | 127 071 781 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 700 | 506 543 | -0,33 | 251,39 | -427 368 | 127 341 466 |
| 2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 508 243 | 2,52 | 8,67 | 108 334 | 4 404 790 |
| 2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -157 | 495 743 | -0,03 | 277,70 | -43 599 | 137 668 129 | |
| 2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 14 603 | -25,00 | ||||
| 2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 495 900 | 0,99 | ||||
| 2015-01-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | -461 | 491 032 | -0,09 | 176,49 | -81 360 | 86 660 126 | |
| 2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 19 471 | -20,00 | ||||
| 2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 491 493 | 1,00 | ||||
| 2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -31 | 51 891 | -0,06 | ||||
| 2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -6 685 | 36 314 | -15,55 | ||||
| 2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 31 | 486 625 | 0,01 | 21,50 | 666 | 10 462 438 | |
| 2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 685 | 486 594 | 1,39 | 8,67 | 57 937 | 4 217 164 | |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -10 000 | 146 628 | -6,38 | |||
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -500 | 479 909 | -0,10 | 262,46 | -131 231 | 125 957 876 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 950 | 480 409 | -0,61 | 261,71 | -772 034 | 125 726 110 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 166 | 483 359 | -0,65 | 260,68 | -825 300 | 126 000 091 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 100 | 486 525 | -0,23 | 259,47 | -285 420 | 126 239 955 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -400 | 487 625 | -0,08 | 257,96 | -103 184 | 125 787 745 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 488 025 | -0,04 | 256,54 | -51 308 | 125 196 713 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -300 | 488 225 | -0,06 | 255,30 | -76 589 | 124 642 231 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -500 | 488 525 | -0,10 | 254,29 | -127 146 | 124 227 755 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -300 | 489 025 | -0,06 | 252,90 | -75 870 | 123 674 422 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -384 | 489 325 | -0,08 | 250,80 | -96 308 | 122 723 738 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 489 709 | -0,02 | 249,69 | -24 969 | 122 275 440 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 489 809 | -0,02 | 247,66 | -24 766 | 121 306 097 |
| 2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 489 909 | 2,08 | 8,67 | 86 667 | 4 245 894 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -10 000 | 156 628 | -6,00 | |||
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 867 | 24 339 | -16,66 | ||||
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 479 909 | -0,04 | 234,94 | -46 987 | 112 748 045 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 480 109 | -0,02 | 233,74 | -23 374 | 112 220 678 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -300 | 480 209 | -0,06 | 232,15 | -69 645 | 111 480 519 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -700 | 480 509 | -0,15 | 231,31 | -161 920 | 111 148 603 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -600 | 481 209 | -0,12 | 230,30 | -138 181 | 110 823 251 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 750 | 481 809 | -0,36 | 229,30 | -401 272 | 110 477 840 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 500 | 483 559 | -0,72 | 228,45 | -799 578 | 110 469 537 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 450 | 487 059 | -0,30 | 227,64 | -330 082 | 110 875 621 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 400 | 488 509 | -0,29 | 226,53 | -317 147 | 110 663 751 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 489 909 | 2,08 | 8,67 | 86 667 | 4 245 894 |
| 2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 867 | 479 909 | 1,02 | ||||
| 2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | -10 000 | 166 628 | -5,66 | |||
| 2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 475 042 | -0,04 | 289,72 | -57 943 | 137 626 793 |
| 2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -800 | 475 242 | -0,17 | 288,16 | -230 532 | 136 948 111 |
| 2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 600 | 476 042 | -0,33 | 287,48 | -459 969 | 136 852 983 |
| 2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 800 | 477 642 | -0,79 | 286,42 | -1 088 410 | 136 807 989 |
| 2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 600 | 481 442 | -0,74 | 285,56 | -1 028 028 | 137 482 214 |
| 2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 485 042 | 2,11 | 8,67 | 86 667 | 4 203 714 |
| 2014-08-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | -10 000 | 176 628 | -5,36 | |||
| 2014-08-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 475 042 | -2,06 | 226,72 | -2 267 198 | 107 701 427 |
| 2014-08-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 485 042 | 2,11 | 8,67 | 86 667 | 4 203 714 |
| 2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | -10 000 | 186 628 | -5,09 | |||
| 2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 29 206 | -14,29 | ||||
| 2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 475 042 | -2,06 | 250,61 | -2 506 121 | 119 051 273 |
| 2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 485 042 | 2,11 | 8,67 | 86 667 | 4 203 714 |
| 2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 475 042 | 1,04 | ||||
| 2014-06-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 196 628 | -4,84 | |||
| 2014-06-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 470 174 | -2,08 | 230,60 | -2 305 993 | 108 421 795 |
| 2014-06-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 480 174 | 2,13 | 8,67 | 86 667 | 4 161 524 |
| 2014-05-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 206 628 | -4,62 | |||
| 2014-05-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 470 174 | -2,08 | 263,17 | -2 631 661 | 123 733 858 |
| 2014-05-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 480 174 | 2,13 | 8,67 | 86 667 | 4 161 524 |
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 216 628 | -4,41 | |||
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 470 174 | -2,08 | 242,22 | -2 422 166 | 113 883 948 |
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 480 174 | 2,13 | 8,67 | 86 667 | 4 161 524 |
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | -2 866 | 42 999 | -6,25 | ||||
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | -14 332 | 226 628 | -5,95 | ||||
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | -13 111 | 0 | -100,00 | ||||
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 866 | 470 174 | 0,61 | 8,67 | 24 839 | 4 074 857 | |
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 332 | 467 308 | 3,16 | 8,67 | 124 211 | 4 050 018 | |
| 2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 111 | 452 976 | 2,98 | 2,89 | 37 876 | 1 308 602 | |
| 2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 22 931 | 22 931 | |||||
| 2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 5 733 | 5 733 | |||||
| 2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 4 699 | 439 865 | 1,08 | ||||
| 2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 34 074 | -12,50 | ||||
| 2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 868 | 435 166 | 1,13 | ||||
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -10 000 | 240 960 | -3,98 | |||
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -10 000 | 430 298 | -2,27 | 273,68 | -2 736 767 | 117 762 537 |
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 10 000 | 440 298 | 2,32 | 8,67 | 86 667 | 3 815 931 |
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -12 850 | 13 111 | -49,50 | ||||
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | -8 653 | 0 | -100,00 | ||||
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 12 850 | 438 138 | 3,02 | 2,89 | 37 122 | 1 265 737 | |
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 653 | 425 288 | 2,08 | 2,89 | 24 998 | 1 228 615 | |
| 2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
G - Gift | -7 840 | 430 298 | -1,79 | ||||
| 2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 38 942 | -11,11 | ||||
| 2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 868 | 416 635 | 1,18 | ||||
| 2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 867 | 43 810 | -10,00 | ||||
| 2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 867 | 406 899 | 1,21 | ||||
| 2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -12 500 | 20 911 | -37,41 | |||
| 2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -12 500 | 20 911 | -37,41 | |||
| 2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -25 000 | 402 032 | -5,85 | 52,00 | -1 300 000 | 20 905 664 |
| 2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 500 | 427 032 | 3,02 | 9,82 | 122 779 | 4 194 436 |
| 2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 500 | 427 032 | 3,02 | 9,82 | 122 779 | 4 194 436 |
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -7 694 | 33 411 | -18,72 | |||
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -3 906 | 12 500 | -23,81 | |||
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -9 804 | 402 032 | -2,38 | 49,05 | -480 886 | 19 719 670 |
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 796 | 411 836 | -0,43 | 48,51 | -87 124 | 19 978 164 |
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 7 694 | 413 632 | 1,90 | 9,82 | 75 573 | 4 062 818 |
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 906 | 405 938 | 0,97 | 9,82 | 38 366 | 3 987 245 |
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -900 | 16 406 | -5,20 | |||
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -900 | 402 032 | -0,22 | 49,65 | -44 684 | 19 960 487 |
| 2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 900 | 402 932 | 0,22 | 9,82 | 8 840 | 3 957 719 |
| 2013-08-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -12 500 | 17 306 | -41,94 | |||
| 2013-08-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -12 500 | 402 032 | -3,02 | 45,98 | -574 724 | 18 484 587 |
| 2013-08-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 500 | 414 532 | 3,11 | 9,82 | 122 779 | 4 071 658 |
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -21 700 | 29 806 | -42,13 | |||
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 659 | 402 032 | -0,41 | 50,64 | -84 008 | 20 357 976 |
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -20 041 | 403 691 | -4,73 | 49,78 | -997 675 | 20 096 424 |
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 21 700 | 423 732 | 5,40 | 9,82 | 213 144 | 4 162 023 |
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -3 300 | 51 506 | -6,02 | |||
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 300 | 402 032 | -0,32 | 51,83 | -67 374 | 20 835 670 |
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 000 | 403 332 | -0,49 | 51,04 | -102 072 | 20 584 412 |
| 2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 300 | 405 332 | 0,82 | 9,82 | 32 414 | 3 981 293 |
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -10 097 | 54 806 | -15,56 | |||
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -2 403 | 0 | -100,00 | |||
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -12 500 | 402 032 | -3,02 | 48,26 | -603 259 | 19 402 346 |
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 10 097 | 414 532 | 2,50 | 9,82 | 99 176 | 4 071 658 |
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 403 | 404 435 | 0,60 | 9,82 | 23 603 | 3 972 482 |
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -25 000 | 2 403 | -91,23 | |||
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -25 000 | 402 032 | -5,85 | 45,41 | -1 135 200 | 18 255 469 |
| 2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 25 000 | 427 032 | 6,22 | 9,82 | 245 558 | 4 194 436 |
| 2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -4 868 | 48 677 | -9,09 | ||||
| 2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 868 | 406 900 | 1,21 | ||||
| 2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -12 300 | 27 403 | -30,98 | |||
| 2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -12 300 | 402 032 | -2,97 | 40,06 | -492 745 | 16 105 643 |
| 2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 300 | 414 332 | 3,06 | 9,82 | 120 814 | 4 069 693 |
| 2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -200 | 39 703 | -0,50 | |||
| 2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -200 | 402 032 | -0,05 | 40,00 | -8 000 | 16 081 280 |
| 2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 200 | 402 232 | 0,05 | 9,82 | 1 964 | 3 950 843 |
| 2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -16 000 | 39 903 | -28,62 | |||
| 2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -16 000 | 402 032 | -3,83 | 38,35 | -613 597 | 15 417 847 |
| 2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 16 000 | 418 032 | 3,98 | 9,82 | 157 157 | 4 106 036 |
| 2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | -9 000 | 55 903 | -13,87 | |||
| 2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | -9 000 | 402 032 | -2,19 | 38,08 | -342 751 | 15 310 745 |
| 2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 9 000 | 411 032 | 2,24 | 9,82 | 88 401 | 4 037 280 |
| 2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 65 000 | 65 000 | |||||
| 2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
A - Award | 7 700 | 402 032 | 1,95 | ||||
| 2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -24 339 | 53 545 | -31,25 | ||||
| 2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
F - Taxes | -10 774 | 394 332 | -2,66 | 34,57 | -372 457 | 13 632 057 | |
| 2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 24 339 | 405 106 | 6,39 | ||||
| 2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 51 922 | 51 922 | |||||
| 2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 77 884 | 77 884 | |||||
| 2012-10-10 | 3 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
380 767 |
